IDiyas

For the Inventor, By the Inventor

San Diego, CA, United States of America

Ronald J Albers

USPTO Granted Patents = 11


 

Average Co-Inventor Count = 12.5

ph-index = 11

Forward Citations = 329(Granted Patents)


Location History:

  • La Jolla, CA (US) (2005 - 2007)
  • San Diego, CA (US) (2009 - 2013)

Company Filing History:

goldMedal11 out of 169 
 
Signal Pharmaceuticals, Inc.
 patents
silverMedal1 out of 52 
 
Pharmacopeia Drug Discovery, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2005-2013

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):
1. 8383634 - Methods of treatment using heteroaryl compounds and compositions thereof (2013-02-26),
2. 8372976 - Methods of treatment comprising the administration of heteroaryl compounds (2013-02-12),
3. 8101588 - Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith (2012-01-24),
4. 7981893 - Heteroaryl compounds, compositions thereof, and methods of treatment therewith (2011-07-19),
5. 7968556 - Heteroaryl compounds, compositions thereof, and methods of treatment therewith (2011-06-28),
6. 7723340 - Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith (2010-05-25),
7. 7521446 - Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith (2009-04-21),
8. 7220771 - Methods of using indazole derivatives as JNK inhibitors (2007-05-22),
9. 7211594 - Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith (2007-05-01),
10. 7208513 - Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith (2007-04-24),
11. 6897231 - Indazole derivatives as JNK inhibitors and compositions and methods related thereto (2005-05-24),

Title: The Innovative Contributions of Ronald J Albers

Introduction

Ronald J Albers is a prominent inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of heteroaryl compounds. With a total of 11 patents to his name, Albers has established himself as a key figure in the innovation of methods for treating various medical conditions.

Latest Patents

Albers' latest patents focus on methods of treatment using heteroaryl compounds. One of his notable patents describes the administration of heteroaryl compounds for treating or preventing cancer, inflammatory conditions, immunological conditions, and metabolic conditions. The compounds are designed to inhibit kinase pathways, providing effective treatment options for patients in need.

Career Highlights

Throughout his career, Ronald J Albers has worked with several notable companies, including Signal Pharmaceuticals and Pharmacopeia Drug Discovery. His work in these organizations has contributed to advancements in drug discovery and development, particularly in the area of targeted therapies.

Collaborations

Albers has collaborated with esteemed colleagues such as John J Sapienza and Maria Mercedes Delgado Mederos. These partnerships have fostered innovation and have been instrumental in the progress of his research and development efforts.

Conclusion

Ronald J Albers is a distinguished inventor whose work has significantly impacted the pharmaceutical industry. His innovative approaches to treatment using heteroaryl compounds continue to pave the way for new therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…